Suchergebnisse - (Subject:"ritonavir")

PubPharm (6.437)

41

Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19 : a systematic review and meta-analysis

enthalten in: Expert review of anti-infective therapy | 2024

von Amani, B. | Amani, B.

42

Nirmatrelvir and ritonavir

enthalten in: Clinical therapeutics | 2024

von Beninger, P.

43

The effects of nirmatrelvir/ritonavir on tacrolimus levels in lung transplant recipients : A single-center study

enthalten in: Pulmonary pharmacology & therapeutics | 2024

von Wang, X. | Du, W. | Zhang, D. | +2

44

Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Guzmán Cordero, C. | Sáez-Torres de Vicente, M. | Jiménez Espinosa, �. | +1

45

Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Yang, H. | Yu, X. | Hou, W. | +8

46

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

enthalten in: Cancers | 2024

von Haddad, A. | Hachem, R. | Moussa, M. | +5

47

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Yang, Z. | Xu, Y. | Zheng, R. | +28

48

Nirmatrelvir/ritonavir for COVID-19 : an overview of systematic reviews

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Cruciani, M. | Pati, I. | Masiello, F. | +2

49

Evaluation of physicians prescribing of COVID-19 guideline-directed outpatient treatments in a primary care walk-in clinic

enthalten in: Journal of the American Pharmacists Association : JAPhA | 2024

von Denning, K. | Sheppard, J. | Carico, R.

50

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11